Genomics
Developer of a genetic inference technology designed to lead the genomic transformation by finding new drug targets for serious diseases. The company uses an analytical platform for genomic sequence d...
Valuation
$161.6M
Market implied
Share Price
N/A
Total Raised
$142.2M
Last Round
N/A